The U.S. Food and Drug Administration is poised to approve Pfizer’s COVID booster shots for all American adults as early as Thursday. That would make tens of millions more Americans eligible for the booster doses, sources familiar with the plan told The New York Times. The FDA is expected to make its decision without the… read on > read on >










-300x200.jpeg)








